Symbol | Exchange | Currency |
|---|
By Vlad SchepkovShares of Tonix Pharmaceuticals (NASDAQ:TNXP) are keeping traders busy early into Wednesday’s trading session, soaring close to 50% in heavy trading, on the news...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Technology, Consumer Services and Consumer Goods sectors led shares lower. At the close in...
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Consumer Services and Consumer Goods sectors led shares higher. At the close in...
Shares of SAExploration Holdings, Inc. (NASDAQ:SAEX) surged 33% after the company announced two new projects worth $42 million in offshore West Africa.Shares of Tonix...
Shares of Facebook, Inc. (NASDAQ:FB) dropped 2.7% after reports flashed that FTC is considering seeking a preliminary injunction over antitrust concerns related to how its...
With the commencement of enrolment for the pivotal Phase III HONOR study of TNX-102 SL in military-related, post-traumatic stress disorder (PTSD), the future of Tonix (NASDAQ:TNXP)...
Tonix Pharmaceuticals Holding Corp. (Tonix) is a clinical-stage biopharmaceutical company. It is focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonixs portfolio is primarily composed of immunology and central nervous system (CNS) and infectious disease product candidates. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases, and cancer. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its infectious disease portfolio of product candidates includes vaccines to prevent COVID-19, an antiviral to treat COVID-19, and treatment for long COVID. The infectious disease portfolio also includes a vaccine in development to prevent smallpox and monkeypox. Its product candidates include TNX-1500, TNX-1300, TNX-102 SL, TNX-102 SL, TNX-102 SL,TNX-1900,TNX-601 CR, and TNX-1900.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Neutral | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 8.09 | 8.09 | 7.85 | -0.28 | -3.33% | 3.02M | NYSE | |||
| 31.51 | 31.55 | 30.71 | -1.24 | -3.79% | 3.56M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 45.27 | 45.38 | 44.78 | -0.99 | -2.14% | 1.01M | NYSE | |||
| 1.07 | 1.09 | 1.05 | -0.0300 | -2.73% | 68.89K | NYSE | |||
| 3.535 | 3.54 | 3.47 | -0.065 | -1.81% | 6.11M | NYSE | |||
| 1.1687 | 1.19 | 1.15 | -0.0413 | -3.41% | 1.53M | NYSE | |||
| 122.89 | 123.13 | 121.57 | +0.24 | +0.20% | 5.39M | NASDAQ | |||
| 49.59 | 50.06 | 49.40 | -0.52 | -1.04% | 5.42M | NYSE | |||
| 13.83 | 17.87 | 9.25 | +5.61 | +68.24% | 37.52M | NASDAQ | |||
| 39.55 | 40.38 | 38.81 | -1.19 | -2.92% | 2.62M | NYSE | |||
| 15.20 | 15.24 | 15.00 | -0.02 | -0.13% | 1.20M | OTC Markets | |||
| 128.27 | 128.29 | 126.93 | +0.07 | +0.05% | 350.60K | NYSE | |||
| 49.52 | 49.52 | 47.44 | -1.37 | -2.69% | 1.26M | NYSE | |||
| 0.0006 | 0.0006 | 0.0006 | 0.00000 | 0.00% | 0.00 | OTC Markets |